Ryan Specialty (NYSE:RYAN – Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02), Zacks reports. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%.
Ryan Specialty Price Performance
RYAN traded down $0.67 during midday trading on Thursday, hitting $68.70. The company had a trading volume of 697,095 shares, compared to its average volume of 947,339. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The company has a market capitalization of $17.99 billion, a PE ratio of 89.23, a P/E/G ratio of 1.21 and a beta of 0.72. Ryan Specialty has a twelve month low of $45.55 and a twelve month high of $75.97. The firm’s 50-day simple moving average is $65.58 and its 200-day simple moving average is $67.25.
Wall Street Analysts Forecast Growth
A number of brokerages recently issued reports on RYAN. Keefe, Bruyette & Woods dropped their target price on shares of Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating for the company in a research report on Friday, January 10th. Wells Fargo & Company dropped their target price on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating for the company in a research report on Tuesday, January 14th. Morgan Stanley began coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They set an “overweight” rating and a $90.00 target price for the company. Finally, Barclays increased their target price on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research report on Thursday, November 21st. One analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, Ryan Specialty presently has a consensus rating of “Hold” and a consensus target price of $74.40.
Insider Buying and Selling at Ryan Specialty
In other news, Director Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $66.71, for a total transaction of $2,334,850.00. Following the completion of the sale, the director now owns 60,200 shares in the company, valued at $4,015,942. The trade was a 36.76 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In the last 90 days, insiders sold 316,451 shares of company stock worth $20,907,793. 11.10% of the stock is currently owned by corporate insiders.
Ryan Specialty Company Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Read More
- Five stocks we like better than Ryan Specialty
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Manufacturing Stocks Investing
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.